Microban® International announces a new range of antiviral technologies
NORTH CAROLINA, USA
- News Direct - 9 November 2021 - Microban International, the global leader in
antimicrobial solutions, odour control and residual sanitisation/disinfection
solutions, is pleased to announce a new range of antiviral technologies that are
proven to reduce viral loading on products and surfaces. Microban has long been
a trusted partner in a wide range of sectors – from consumer and healthcare to
industrial and construction – and this announcement adds to the versatility of
the company's technology portfolio.
Microban® technology can be incorporated into various materials during
manufacturing, becoming part of the product's structure to provide inherent and
enduring protection from microbes. Recent data demonstrates that new antiviral technologies
from Microban conform to both ISO 18184 – which assesses the antiviral performance
of treated textile products, such as woven and knitted fabrics, fibres, yarns,
and braids – and ISO 21702, which measures activity in treated plastics and
other non-porous surfaces. Thorough testing was performed to evaluate the
efficacy of each product type against many viruses, including bacteriophage
Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles
treated with these technologies can now benefit from reduced viral loading* by up
to 99 %.
Antiviral technologies from Microban inhibit the viruses' ability to
remain viable on surfaces. The modes of action vary, disrupting the structure
of either the outer protein coat – to prevent viruses from recognising or
binding to host cells – or nucleic acid payload, to prevent viral replication.
This gives manufacturers a valuable product feature and provides consumers with
added peace of mind.
Michael Ruby, President of Microban International, explained: "We are
excited with the latest results confirming the antiviral activity of our new technologies.
Assessing antiviral efficacy in treated products to a standard that meets the
complex regulatory landscape is an arduous process, but we have been confident
throughout that our innovative solutions conformed to the rigorous ISO
standards. Our world-class research team and global in-house regulatory
department worked diligently to ensure that the technology is recognised as effective
and compliant across various markets, to support partners with their claims and
give customers even greater confidence in products protected with Microban antiviral
Following the start of the COVID-19 pandemic, there was a monumental
upsurge in demand for antiviral technology in products and it is readily acknowledged
that Microban was not the first in the industry to make antiviral claims.
Instead, the company invested a considerable amount of time and resources to ensure
that its antiviral technologies were not only scientifically proven to be
effective in reducing viral loading on surfaces and products, but that they
could also be used in a regulatory compliant manner by brands and manufacturers
across a variety of territories and product types. Microban is committed to being
a reliable and trusted industry leader, and its unrivalled regulatory expertise
can help to ensure that partners are aware of the implications that antiviral
claims can have on their product types in the countries where they are being
*Antiviral efficacy may vary
depending on substrate type, application dosage of the treatment, impurities,
and application procedure. Only
Microban antiviral technologies that are registered with US EPA and are EU BPR
compliant are being offered for sale. In the US, antiviral technologies may
only be incorporated into products that are or will be registered with the US
EPA. Contact your Microban representative for further
The issuer is solely responsible for the content of this announcement.
About Microban International:
Part of Barr Brands
International (BBI), Microban International is home to the most trusted
and well-known global brands in the antimicrobial, odour
control, and sanitisation / disinfection markets – Microban® and Ultra-Fresh®. Our organisation
has experienced over 100 collective years of growth and has revolutionised the
industry. As the global leader, our proactive systems keep products
cleaner, and control odours better by preventing problems before they start.
Microban International drives innovation by combining science and creative
solutions that enhance high-quality consumer, textile, industrial and medical
products around the world. Today, the Microban and Ultra-Fresh brands and our
technologies are featured on thousands of products worldwide. The company is
headquartered in North Carolina with operations in North America, Europe, and
Asia Pacific. For more information, please visit www.microban.com.